Literature DB >> 13843706

Vaccination against tuberculosis with nonliving vaccines. I. The problem and its historical background.

D W WEISS.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS/immunology

Mesh:

Substances:

Year:  1959        PMID: 13843706     DOI: 10.1164/arrd.1959.80.3.340

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  7 in total

Review 1.  Immunization against tuberculosis: what kind of vaccine?

Authors:  A J Crowle
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

2.  Immunizing capacity of viable and killed attenuated mycobacterial cells against experimental tuberculous infection.

Authors:  G P Youmans; A S Youmans
Journal:  J Bacteriol       Date:  1969-01       Impact factor: 3.490

3.  Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations.

Authors:  A S Youmans; G P Youmans
Journal:  J Bacteriol       Date:  1969-07       Impact factor: 3.490

4.  Streptomycin-dependent exhibition of cytokine-inducing activity in streptomycin-dependent Mycobacterium tuberculosis strain 18b.

Authors:  Yutaka Fukasawa; Ikuo Kawamura; Ryosuke Uchiyama; Kazuhiro Yamamoto; Taijin Kaku; Takanari Tominaga; Takamasa Nomura; Satoshi Ichiyama; Takayuki Ezaki; Masao Mitsuyama
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

5.  Induction of immunity against live Mycobacterium lepraemurium: a requirement for viable bacilli?

Authors:  M Løvik; O Closs
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

6.  Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals.

Authors:  D W Smith; E Wiegeshaus; R Navalkar; A A Grover
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

7.  STUDIES ON THE HETEROLOGOUS IMMUNOGENICITY OF A MENTHANOL-INSOLUBLE FRACTION OF ATTENUATED TUBERCLE BACILLI (BCG). I. ANTIMICROBIAL PROTECTION.

Authors:  D W WEISS; R S BONHAG; J A PARKS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.